European Journal of Drug Metabolism and Pharmacokinetics invites submission of Original Research, Practical Application, Current Opinion and Review Articles on the topics of preclinical and clinical pharmacokinetics and pharmacodynamics.
European Journal of Drug Metabolism and Pharmacokinetics promotes drug development by providing researchers essential information on preclinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy.
European Journal of Drug Metabolism and Pharmacokinetics offers a range of additional enhanced features (including slide sets, videos and animations) designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers in understanding important medical advances. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
- Jasbir Singh
- Publishing model
- Hybrid. Open Choice – What is this?
- Impact factor: 1.497 (2018)
- Five year impact factor: 1.453 (2018)
- Submission to first decision: 18 days
- Downloads: 55,730 (2018)